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Abstract  33 
 34 
The liver harbors a rich, diverse spectrum of innate and adaptive immune cells. In 35 
homeostasis, these immune cells perform host defense against gut-derived 36 
pathogens and mediate tolerance to self-antigens. Following tissue injury there are 37 
complex interactions within the immune cell compartment which regulate liver 38 
regeneration and repair. Partial hepatectomy (PHx) and acetaminophen induced liver 39 
injury (AILI) are clinically relevant models of liver injury, which are commonly used to 40 
study liver regeneration. Here we discuss how the innate and adaptive immune 41 
systems influence liver regeneration and repair following acute hepatic injury.  42 
 43 
Introduction 44 
 45 
The mammalian liver is a multifunctional organ with a unique ability to regenerate 46 
following tissue injury. This evolutionary adaptation sets the liver apart from other 47 
organs, enabling it to detoxify various drugs and toxins whilst simultaneously 48 
regenerating after injury. Despite this well-orchestrated process of regeneration, 49 
mortality rates from liver disease have continued to rise inexorably since the 1970s 1. 50 
In advanced chronic liver disease, the regenerative and reparative capacity of the 51 
liver diminishes and transplantation is the only curative option for patients 2. 52 
Shortages in the availability of donor organs and the requirement for life-long 53 
immunosuppression following liver transplantation, means that potent pro-54 
regenerative therapies are urgently required. A deeper understanding of the cellular 55 
and molecular mechanisms which drive liver repair and regeneration, will hopefully 56 
facilitate the development of potent new therapies for patients with liver disease 3.  57 
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 58 
Around 80% of the liver mass is comprised of hepatocytes, and these cells are 59 
integral to the myriad functions of the liver, namely: metabolic homeostasis, storage 60 
of nutrients, secretion of bile and detoxification of harmful drugs. Hepatocytes are 61 
quiescent in homeostatic conditions, at any given time less than 1-2% of hepatocytes 62 
are in the cell cycle 4, but during injury they re-enter the cell cycle. Although liver 63 
regeneration is characterized by proliferation of hepatocytes, the induction of 64 
proliferation is also achieved through cytokine-driven interactions with non-65 
parenchymal cells (NPCs), which constitute approximately 20% of the liver mass. 66 
These cells include liver sinusoidal endothelial cells (LSEC), hepatic stellate cells 67 
(HSC), and hepatic immune cells (Figure1).  68 
 69 
As the largest internal organ, exposed to both the portal and arterial circulation, the 70 
liver harbors an extensive reservoir of resident immune cells. These hepatic immune 71 
cells form a “firewall” to mediate host defense against blood-borne pathogens and 72 
maintain tolerance to non-self-antigens from nutrients or resident microbiota 5. 73 
Following liver injury, dynamic changes in the hepatic immune cell compartment are 74 
observed at a tissue, cellular and genetic level, which have a critical role in 75 
orchestrating liver regeneration and repair.  76 
 77 
Models of Liver Regeneration  78 
 79 
In order to study the mechanisms underpinning liver regeneration, pre-clinical 80 
models have been utilized to induce hepatocyte injury, and stimulate parenchymal 81 
and non-parenchymal cell replication 6,7. These rodent models are frequently used to 82 
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dissect hepatic immunity in homeostasis and disease and highlight their importance 83 
in the regulation of liver regeneration and repair. Advancements in transgenic animal 84 
technology, which enable selective interrogation of immune cell function, have 85 
greatly increased our understanding of the role of immune cells in liver injury and 86 
repair 8. However, there are distinct differences in the immune cell composition and 87 
marker expression between humans and rodents, and therefore, as always, care 88 
must be taken in extrapolating data from rodents to humans. Despite these 89 
limitations, these models continue to give important mechanistic insights into how the 90 
immune cell compartment regulates liver regeneration.  91 
 92 
Partial Hepatectomy (PHx) 93 
 94 
In a clinical setting, liver resection is one of the main treatments for hepatic 95 
malignancies and the repair of trauma 9. To study the mechanisms underpinning this 96 
remarkable regenerative process, rodent partial hepatectomy (PHx) has become a 97 
standard pre-clinical model, where 2/3 of the rodent liver is removed surgically 7,9. 98 
Once the lobules are removed, regeneration is initiated immediately, with the 99 
remnant lobes enlarging via compensatory hyperplasia, until the original mass of the 100 
liver is reached, a process which takes approximately 7 days 7,10. These rodent 101 
models have facilitated a detailed interrogation of this regenerative process, 102 
highlighting cellular kinetics, molecular mechanisms and key signaling pathways 103 
10,11
. Hepatocyte proliferation in C57BL/6 mice peaks around 36-48 hours post-104 
resection 12. This process is mediated by complex cross-talk between hepatocytes 105 
and NPCs 11. Importantly, this model does not reflect the significant inflammatory 106 
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responses that can occur in pathological conditions of human acute and chronic liver 107 
injury, where liver regeneration may be compromised.  108 
 109 
 AILI 110 
 111 
Acute liver failure (ALF) in humans is associated with high mortality rates, brought 112 
about by hepatic parenchymal cell death, extensive intra-hepatic inflammation and a 113 
systemic inflammatory response (SIRS) 13,14. This overwhelming inflammation 114 
contributes to multiple organ dysfunction and death 15. Acetaminophen (APAP) 115 
poisoning is the commonest cause of ALF in western countries 3. Following ingestion 116 
of recommended doses of APAP, hepatocytes are protected against its toxic 117 
metabolite: N-acetyl-p-benzoquinone (NAPQI), due to detoxification by glutathione. 118 
However, at higher doses of APAP, glutathione is depleted by NAPQI, and leads to 119 
hepatocyte death. In toxic injuries, liver regeneration is a dose dependent process, it 120 
increases with the extent of hepatic injury until a threshold is reached where 121 
increasing hepatic injury inhibits the regenerative process, accelerating the 122 
progression to ALF 16. AILI can be modeled in rodents by a single dose of APAP, 123 
with similar histological and biochemical features to those seen in human ALF 15,17. 124 
  125 
APAP-induced liver injury (AILI) is a bi-phasic process, initial stages involve 126 
hepatocyte necrosis from covalent binding of NAPQI to cellular proteins causing 127 
mitochondrial dysfunction, oxidative stress and peroxynitrite formation 18. The 128 
secondary phase of the injury is characterized by intrahepatic and systemic 129 
inflammation (Figure 2). Inflammation is triggered by the release of “danger 130 
associated molecular patterns” (DAMPs) such as high-mobility group box 1 131 
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(HMGB1) protein and heat shock protein-70 from damaged or dying hepatocytes, 132 
which then activate NPCs through surface-expressed toll-like receptors (TLRs) 19,20. 133 
The use of animal models has enabled comprehensive analysis of the primary 134 
stages of AILI, which has increased our knowledge of the metabolism of APAP by 135 
hepatocytes, and the molecular mechanism by which necrosis occurs 18,21. Despite 136 
this, the current initial therapeutic options for APAP-induced liver injury (AILI) are 137 
limited to the antidote: N-acetyl-cysteine (NAC). NAC reverses hepatotoxicity by 138 
quenching NAPQI, targeting the initial stages of the disease, so therefore must be 139 
given early after APAP poisoning to be effective 22. Recent studies have 140 
demonstrated that the secondary immune response following hepatocyte death is a 141 
crucial determinant in disease progression and contributes to the evolution of extra-142 
hepatic features like SIRS and multi-organ dysfunction 13,15,23.  143 
 144 
Immune Regulation of Liver Regeneration  145 
 146 
As the immune system plays a major regulatory role in the hepatic regenerative and 147 
reparative response, in this review we will describe the known functional roles of 148 
various cell lineages within the immune cell compartment, with emphasis on how 149 
these cells determine the outcome of hepatic injury and repair.  150 
 151 
Macrophages/Monocytes 152 
 153 
When initially discovered, macrophages were described as phagocytic cells in the 154 
circulation, responsible for recognizing, engulfing and degrading foreign pathogens 155 
and cellular debris. Since then, in addition to bone marrow-derived circulating 156 
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monocytes/macrophages, distinct macrophage populations have been discovered in 157 
many tissues of the body 24,25. Liver resident macrophages, termed Kupffer cells 158 
(KCs) represent approximately 20% of the hepatic NPC population26 . They are now 159 
thought to have an embryonic origin in homeostasis, having the capacity to self-160 
renew independently with no contribution from circulation-derived progenitors 27. KCs 161 
have a role in immune surveillance and maintaining tolerogenic responses in the 162 
liver 5,28 (Figure 1). They capture and phagocytose blood borne food antigens and 163 
bacteria from the intestine, whilst preventing immune responses to harmless gut-164 
derived antigens 5,29,30. When homeostasis is disrupted by tissue injury, 165 
macrophages are critical mediators of tissue repair, from initiation and propagation to 166 
resolution of tissue injury 22. KCs are the first immune cells to become activated 167 
through recognition of DAMPs via TLRs on their surface 31,32. This results in the 168 
release of pro- and anti-inflammatory mediators and recruitment of circulatory-169 
derived immune cells into the liver 33 (Figure 2A). 170 
Resident and recruited macrophages seems to be critical for effective liver 171 
regeneration following PHx. Pre-treatment of mice with either liposomal clodronate or 172 
gadolinium chloride to deplete or inhibit macrophages respectively, resulted in 173 
impaired liver regeneration following PHx 34. Liver regeneration is also impaired in 174 
mice where recruitment of monocytes is prevented following PHx 35,36. The 175 
presumed mechanism is that macrophages release pro-reparative cytokines such as 176 
interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α), and hepatocyte growth factor 177 
(HGF), to drive hepatocyte proliferation 34. However, a detailed characterization of 178 
macrophage phenotype following PHx remains lacking. Furthermore, elevated 179 
colony stimulating factor 1 (CSF1), a mitogen and survival factor for macrophages is 180 
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seen in the serum of patients who have undergone PHx 37, suggesting a role for 181 
macrophages in human liver regeneration.  182 
 183 
In AILI the precise role of macrophages remains controversial, with contradictory 184 
studies reporting both deleterious and hepatoprotective functions. Using flow-185 
cytometry-based phenotyping, three subsets of macrophages with distinct gene 186 
expression profiles have been shown to populate the murine liver following AILI: 187 
KCs, Ly6CHi monocyte-derived macrophages (MoMFs) and Ly6CLo MoMFs 38,39. 188 
There are dynamic changes in these subsets of monocytes/macrophages during AILI 189 
38,40
. KCs around the necrotic area are depleted during the necroinflammatory phase 190 
of AILI, whilst during the repair phase their numbers are re-established via self-191 
renewal, independent of MoMFs 38,41. Since these studies do not use a specific, 192 
discriminatory marker it is difficult to know whether “KC disappearance” signifies the 193 
death, migration or plasticity following AILI 38,39,41. A recent study demonstrated how 194 
bacteria-induced early necroptosis of KCs is necessary to orchestrate polarization of 195 
macrophages to a pro-reparative phenotype, promoting liver repair following infection 196 
42
. Future studies using a KC-specific fate mapping strategy could help elucidate 197 
whether “KC disappearance” has any similar functional relevance in AILI. 198 
 199 
The role of KCs in AILI has been studied primarily using clodronate liposome 200 
mediated depletion. However, in addition to depleting KCs, clodronate liposomes 201 
also deplete other types of liver macrophages and monocytes. Therefore this is an 202 
imperfect experimental system for specifically studying the role of KCs in AILI. 203 
Despite these technical limitations, mice treated with clodronate liposomes display 204 
significantly increased hepatic injury and necrosis following AILI 43–45. Cytokine 205 
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analysis of KCs during AILI demonstrates that  these cells are major producers of 206 
hepatocyte mitogens such as IL-6, TNF-α and IL-10 44,46. Interestingly, microarray 207 
profiling of KCs from a post-APAP livers compared to healthy livers display very little 208 
differences in their transcriptome 38. More targeted, high resolution techniques, 209 
which also considers the spatial distribution of KCs could give significantly more 210 
information regarding their precise role in AILI.   211 
 212 
Circulatory-derived monocytes and macrophages (MoMFs), that are distinct from 213 
resident KCs, have also been implicated in the pathogenesis of AILI 38,39,47. During 214 
the necroinflammatory phase, Ly6CHi monocytes can infiltrate the liver through C-C 215 
chemokine receptor 2 (CCR2) and C-C chemokine ligand 2 (CCL2)-dependent 216 
transmigration 48,49. Once in the liver they differentiate into macrophages (MoMFs) 217 
and aggregate around the necrotic areas 38,39 (Figure 2A). Eliminating monocytes 218 
and MoMFs from the liver during AILI, by inhibition of CCR2 -CCL2 interaction, 219 
results in exaggerated hepatic injury 38,50–52. Conversely, Ly6CHi monocytes have an 220 
overall pro-inflammatory transcription profile, which can aggravate the early phase of 221 
AILI 39. These apparently contradictory findings can be explained by the plasticity of 222 
MoMFs. Upon maturation, these pro-inflammatory Ly6CHi monocytes acquire a pro-223 
reparative phenotype, where angiogenic and tissue remodeling factors such as 224 
vascular growth factor A (VEGFA) and fibronectin are upregulated in these cells 38. 225 
They polarize to ephemeral Ly6CLo CCR2Lo CX3CR1Hi macrophages (MoMFs) that 226 
promote angiogenesis, tissue remodeling and necrotic cell clearance 38 (Figure 2B).    227 
 228 
These data suggest that specific subsets of macrophages promote a niche which 229 
supports clearance of cellular debris and an anti-inflammatory phenotype, promoting 230 
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live repair and regeneration 40,53. In addition to these pro-reparative responses 231 
macrophages also have a pivotal role in mediating the broader immune response 232 
during AILI. Due to increased gut permeability, the capacity of the liver to maintain 233 
an effective immune barrier against gut-derived pathogens is markedly reduced 234 
during liver injury 54. Thus, activation of hepatic macrophages is a key regulatory 235 
process during liver injury, not only mediating tissue repair but also combating the 236 
influx of pathogens into the liver and preventing their spread systemically 55. In line 237 
with this, sepsis and/or SIRS have been identified as major factors contributing to 238 
worsening hepatic encephalopathy in ALF, conferring poor prognosis 13,15.  239 
 240 
Macrophages have been shown to be important in human AILI. Pro-inflammatory 241 
and pro-resolution monocyte/macrophages, analogous to subsets identified in 242 
mouse models of AILI, have also been described in humans 40,56. Recent studies in 243 
both humans and mice highlight secretory leukocyte protease inhibitor (SLPI)-244 
reprogramming of macrophages to a pro-resolution phenotype (Figure 2B). This 245 
subset of macrophages express a tyrosine kinase receptor (MerTK), which promotes 246 
resolution of inflammation following AILI via enhanced phagocytic capabilities and 247 
neutrophil apoptosis 40. Monocyte reduction and dysfunction can lead to a poor 248 
prognosis in AILI patients and promote ALF 37,56. Consequently, macrophage-based 249 
therapies have been suggested as a treatment for ALF. This has been demonstrated 250 
as a proof of concept in mice, whereby administration of CSF1 was shown to 251 
promote liver regeneration by promoting KC and MoMF proliferation 37. However, 252 
macrophages in the context of AILI can be highly dynamic, adapting rapidly to 253 
changes in the microenvironment 57,58. Therefore, to therapeutically enhance the pro-254 
reparative capabilities of macrophages the signaling cues which promote 255 
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macrophage plasticity and how these changes temporally during AILI needs to be 256 
deciphered.  257 
 258 
Dendritic Cell (DC) 259 
DCs are major antigen presenting cells (APC) in the liver, and constitute 260 
approximately 1% of hepatic NPCs 59. They are primarily found in the portal region, 261 
with sparse distribution in the parenchyma 60. In homeostasis, DCs capture and 262 
process antigens and migrate to lymphoid tissues to mediate tolerogenic responses, 263 
by interacting with effector lymphocytes 59,61 (Figure 1). Mitogens such as fms-like 264 
tyrosine kinase 3 ligand (Flt3L) and granulocyte macrophage colony-stimulating 265 
factor (GM-CSF), can be used to augment DC numbers in the liver 62. Similar to 266 
macrophages, DCs represent a heterogeneous population of cells, consisting of 267 
multiple distinct subsets with varying functional capabilities 63. Current classification 268 
of hepatic DCs in rodents have arisen from multiparametric flow cytometry 269 
experiments and visualization with immunohistochemistry and intravital imaging 64–66. 270 
All DCs express MHCII and CD45 on their surface and based on additional markers, 271 
DCs have been broadly divided into two main subtypes:  conventional DCs (cDCs) 272 
and plasmacytoid DCs (pDCs) 63.  273 
DCs have been shown to exhibit regeneration and repair properties and regulate 274 
liver regeneration  67. PHx causes a marked increase in CD11c+ DC numbers, 275 
without any apparent surface phenotypic changes. In vivo expansion of DCs via 276 
administration of Flt3L significantly increases in liver regeneration 67. DCs also 277 
display a pro-repair cytokine pattern through the upregulation of IL-10, an anti-278 
inflammatory cytokine 52, and downregulation of IFN-γ mRNA, a pro-inflammatory 279 
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cytokine 67,68. DCs have also been shown to influence other cell types such as T 280 
cells following PHx, promoting an anti-inflammatory milieu 67.  281 
In AILI, DCs display a protective role. Transient depletion of DCs in CD11c.DTR 282 
mice results in increased hepatocyte necrosis with elevation in serum liver enzymes 283 
and increased mortality 69. The precise mechanism by which they suppress injury 284 
and promote repair in this setting has not been fully elucidated. APAP overdose does 285 
not result in DC expansion but changes in the DC immune-phenotype, with 286 
increased production of IL-6, TNF-α and CCL2 69,70 (Figure 2). They have also been 287 
shown to negatively influence pro-inflammatory cell types such as neutrophils and 288 
natural killer cells 69. Notably, treatment of mice with the DC mitogen, Flt3L, has a 289 
hepatoprotective phenotype in AILI 69. However, the lack of markers which are 290 
completely exclusive to DCs has been the main limitation in this area. Standardly 291 
used makers such as CD11c and MHC II are also expressed on macrophage 292 
subsets, making it difficult to interpret results of depletion studies using the CD11c-293 
diphtheria toxin system 70. Hence, it currently remains challenging to draw specific 294 
conclusions regarding DC function in the context liver regeneration.  295 
 296 
 297 
  298 
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Figure 1 Immune regulation in liver homeostasis.  299 
 300 
 301 
  302 
Figure 1. In steady state, most of the hepatic parenchyma is comprised of quiescent 
hepatocytes. The NPCs reside in the sinusoids, except for HSCs, which are located in the 
space of Disse. The APCs (KCs, LSECs & DCs) flank the sinusoids, removing antigens from 
circulation via phagocytosis. KCs line the sinusoids to survey the circulation for pathogens, 
antigens and apoptotic bodies. Pathogen interactions can activate other innate immune cells 
such as NK cells via cytokine release, which can aid in the killing of pathogens or infected 
cells through TRAIL/IFN-γ mediated mechanisms. LSECs interact with T cells to induce 
tolerance, generating tolerant T cells and initiating apoptosis of activated T cells (CTLs). 
Immunosuppressive mediators (IL-10, TGFβ and PGE2) released by APCs can also promote 
tolerance in the liver. Abbreviations: CTL, cytotoxic T cells; DC, dendritic cells; HSC, hepatic 
stellate cells; IFN-γ, interferon-γ; IL, interleukin; KC, Kupffer cells; LSEC, liver sinusoidal 
endothelial cells; NK, natural killer cells; PGE2, prostaglandin E2; TGF-β, transforming 
growth factor-β; TRAIL, TNF-related apoptosis-inducing ligand.  
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Figure 2A Early stages of acute liver injury (necroinflammatory phase).  303 
Figure 2A. In response to hepatocyte death various DAMPs such as HMGB1 and H2O2 are 
released and inflammation is initiated. DAMPs activate KCs and neutrophils via TLR-interaction 
and recruit them to the site of injury. KCs and neutrophils can initiate clearance of the necrotic 
debris, and promote hepatic injury and cell death via release of reactive oxygen species (ROS), 
NO, IL-1β, IL-6 and TNF-ɑ. Chemoattractants such as CCL2, and IL-17 released by KCs, DCs 
and T cells facilitate the infiltration of bone marrow-derived leukocytes from the systemic 
circulation to the necrotic sites. During the early stages Ly6CHi monocytes proliferate and 
expand via CSF-1, and contribute to inflammation via release of pro-inflammatory mediators 
(IL-1β, TNF-ɑ). NK and NKT cells also contribute to this pro-inflammatory phenotype through 
IFN-γ-dependent mechanisms. Ly6CHi monocytes can differentiate into a transient population of 
Ly6CLo MoMFs, which are phenotypically distinct from KCs. Abbreviations: CCL2, C-C motif 
chemokine ligand-2; CXCL, C-X-C motif ligand, CSF1, Colony stimulating factor; DAMPs, 
damage associated molecular patterns; HMGB1, heat mobility group box protein-1; Hsp70, 
Heat shock protein-70; MoMFs, monocyte derived macrophages; NKT cells, Natural killer cells; 
NO, nitric oxide; ROS, reactive oxygen species; TNF-ɑ, Tumour necrosis factor-ɑ.  
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Figure 2B Immune cell contribution to resolution following acute liver injury.  304 
 305 
 306 
 307 
 308 
 309 
Figure 2B. KC numbers are re-established via self-renewal and reprogramming of KCs and 
Ly6CLo MoMFs to a pro-resolution macrophage phenotype promotes neutrophil apoptosis. 
Ly6CLo MoMFs and KCs display enhanced phagocytic capabilities and cellular debris is 
cleared via these cells. The lost hepatic parenchyma is replaced via hepatocyte 
proliferation, induced by mitogens such as HGF, IL-6, IL-4, or TGF-β released by immune 
cells. Inflammation is dampened, with reduction of pro-inflammatory cells (Ly6CHi 
monocytes), inhibition of IFN-γ release by NK/NKT cells and release of anti-inflammatory 
mediators. Ly6CHi monocytes reprogram to a pro-resolution phenotype, and together with 
Ly6CLo MoMFs they promote angiogenesis and tissue remodeling. Abbreviations: HGF, 
Hepatocyte growth factor; MMPs, matrix metalloproteinases; SLPI, Secretory leukocyte 
protease inhibitor; VEGA, vascular endothelial growth factor A.  
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Neutrophils 310 
Neutrophils are the most abundant innate immune cells in the systemic circulation, 311 
and are very early responders to infection and inflammation. In the steady state liver, 312 
there are relatively low numbers of neutrophils 71. Inappropriate activation of 313 
neutrophils can contribute to persistent inflammation and promote severe liver 314 
damage 41,72. Neutrophil-mediated liver injury is reported in models of hepatic 315 
ischemia-reperfusion injury 73, alcoholic hepatitis 74, and endotoxemia 75. However, 316 
their role in liver regeneration is still debated. There are limited studies looking at the 317 
role of neutrophils following PHx. One study reports that neutrophils promote liver 318 
regeneration through interaction with intracellular adhesion molecule (ICAM-1), 319 
leading to KC-dependent release of hepatocyte mitogens IL-6 and TNF-α 34. 320 
Neutropenic mice show delayed liver regeneration and reduced hepatic levels of 321 
TNF-α and IL-6 34. Furthermore, significant changes in neutrophil phenotype are 322 
observed in patients who have undergone PHx. This has been proposed to be 323 
important in defense against the influx of gut derived endotoxins following hepatic 324 
resection 76,77. 325 
In the context of AILI, there is a huge infiltration of neutrophils from the circulation 326 
into the site of injury during the early phase 47. HMGB1 and lipid peroxidation 327 
products from dying hepatocytes and pro-inflammatory mediators such as TNF-α 328 
and IL-1 released from KCs, can activate neutrophils and mediate their recruitment 329 
into the hepatic sinusoids 78–80. Neutrophil chemotaxis from sinusoids to injury sites 330 
is regulated by chemokine receptor 2 (CXCR2) and formyl peptide receptor 1 (FPR1) 331 
78,79,81
, leading to neutrophil accumulation, “patrolling” and clearance of necrotic 332 
debris 41,75 (Figure 2A).  333 
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The studies interrogating the functional role of neutrophils in AILI have relied mainly 334 
on inducing neutropenia using anti-GR-1 antibodies. Depletion of neutrophils in mice 335 
prior to APAP overdose, decreased neutrophil recruitment and protected against 336 
liver injury 82. Conversely, anti-GR-1-mediated neutrophil depletion induced after 337 
APAP overdose did not protect against liver injury 72. The protective phenotype seen 338 
with pretreatment of anti-Gr-1 was attributed to a preconditioning effect, where 339 
hepatoprotective genes are induced by KCs activated via antibody-tagged 340 
neutrophils in the sinusoids, prior to APAP challenge 72. Similar attenuation of 341 
hepatic injury is also seen when neutrophil infiltration to the liver parenchyma is 342 
prevented by CXCR2-FPR1 antagonism 79,83. This neutrophil-induced cytotoxicity in 343 
AILI has been attributed to high expression of inducible nitric oxide synthase (iNOS), 344 
which produces NO, a potent mediator of tissue damage 83 (Figure 2A). More recent 345 
studies show that neutrophil-sensing of intracellular DNA deposits at necrotic sites 346 
are a pathogenic feature of AILI, which activates the TLR9/NF-kB and IL-33/ST2 347 
pathways 84. Blocking these interactions resulted in a significant reduction in 348 
systemic inflammation, liver neutrophil recruitment and hepatotoxicity 41,84.  349 
Conversely, inhibiting neutrophil interaction with target cells, or preventing 350 
neutrophil-derived oxidant stress show no effect on hepatotoxicity 71,85,86. The 351 
interplay between neutrophils and other immune cells may also have functional 352 
relevance. Infiltrating monocytes, MDMs and neutrophils were shown to coincide 353 
spatially and temporally during the necroinflammatory and resolution phases of AILI 354 
47
. During the necroinflammatory phase, Ly6CHi monocytes promote neutrophil 355 
activity which facilitates clearance of necrotic debris, whilst during the resolution 356 
phase Ly6CLo MoMFs and KCs facilitate neutrophil clearance 47 (Figure 2B). It is 357 
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important to note that the studies in this area to date have not addressed whether 358 
neutrophils can influence hepatocyte proliferation in the context of liver regeneration.  359 
Clinical assessment of explant livers and blood from patients who developed ALF 360 
from AILI show significant neutrophil dysfunction, including impaired bactericidal 361 
function, akin to that seen in severe sepsis 87. Neutrophilic indices can be important 362 
clinical biomarkers of AILI, and indicators of the development of organ dysfunction 363 
and increased susceptibility to sepsis 87. There is evidence that activated and 364 
functioning neutrophils persist in the liver during the later phase of AILI, suggesting a 365 
potential pro-reparative role for neutrophils 88. Whether neutrophils have a beneficial 366 
or deleterious effect in AILI remains controversial, with variable findings in both 367 
mouse and human studies 87,88. The contradictory evidence in mice may reflect 368 
differences in experimental approaches and techniques, such as animal strains, 369 
APAP dosage and mode of administration, and neutrophil depletion strategies. 370 
Neutrophils may play different roles in AILI at different times during the disease 371 
process, and understanding the precise signals that govern a potential switch 372 
between pro-injury and pro-reparative neutrophil phenotypes may identify novel 373 
therapeutic targets. Furthermore, interactions between neutrophils and other 374 
leukocytes (infiltrating and resident) during AILI warrants further study and as this 375 
may also provide more insight into their role in AILI.  376 
 377 
Eosinophils  378 
Eosinophils have been extensively studied in the context of type 2 innate immunity, 379 
mainly in parasitic infections. Their role in liver regeneration and repair was largely 380 
unexplored until recently. A direct role for eosinophils in liver regeneration was 381 
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demonstrated by Goh et al (2013), where eosinophil-derived IL-4 signals were 382 
shown to promote hepatocyte proliferation following PHx and acute carbon 383 
tetrachloride (CCL4) liver injury. Mice lacking eosinophils show impaired hepatocyte 384 
proliferative capacity following PHx and CCL4 induced liver injury. Increased 385 
eosinophil recruitment to the liver following injury was accompanied by elevated 386 
expression of eotaxin-1, a potent eosinophil chemoattractant 89,90. A similar 387 
eosinophil-mediated type 2 cytokine response is seen in muscle injury, where this 388 
pathway regulates muscle regeneration via IL-4/IL-4Ra signaling 91. Together, these 389 
data suggest an important regulatory role of eosinophils in tissue regeneration. 390 
Although there are no animal studies investigating the role of eosinophils in AILI, 391 
immunohistochemical analysis of livers from patients following drug-induced liver 392 
injury, including some patients with APAP overdose, show significant eosinophil 393 
infiltration 92. Similar to the observation in mice 89, this appears to be related to 394 
eotaxin expression 92. Additionally, eosinophilia was found to be associated with a 395 
better prognosis in patients with acute liver injury secondary to drug-related 396 
aetiologies 93. 397 
 398 
Lymphocytes  399 
 400 
Innate Lymphocytes  401 
 402 
Lymphocytes account for approximately 25% of hepatic NPCs, and innate 403 
lymphocytes constitute approximately 50% of total hepatic lymphocytes in humans 404 
26,70
. They are comprised of natural killer (NK) cells, natural killer T (NKT) cells and 405 
innate lymphoid cells (ILCs) 70. NK cells are a major component of the innate 406 
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immune response, they recognize and destroy foreign pathogens, release 407 
cytokines/chemokines and mediate cytotoxic lysis of virus infected hepatocytes and 408 
tumour cells 94 (Figure 1). NKT cells on the other hand cells are a heterogeneous 409 
subset of lymphocytes expressing both NK and T cell surface markers 95. ILCs are a 410 
recently identified heterogeneous group of cells which share similarities to NK cells. 411 
However, to their recent discovery we know very little about these cells in the context 412 
of liver regeneration 96.  413 
 414 
Both NK and NKT cells are activated following hepatic injury, displaying increased 415 
levels of cytotoxicity 97,98. However, whether these cells drive injury or regeneration 416 
and repair is still unclear. As seen with macrophages and DCs, there is an overlap in 417 
cell surface markers between NK and NKT cells. This means studying the differential 418 
roles of these cells during liver injury is challenging. Following PHx, there is an 419 
accumulation of NK and NKT cells in the liver 98,99. Preferential depletion of NK cells 420 
via anti-ASGM-1 treatment suggests they are negative regulators of liver 421 
regeneration, partly through IFN-γ dependent mechanisms 98. In their absence 422 
hepatocyte proliferation is enhanced with no apparent changes in liver injury or rate 423 
and amount of liver mass restoration 98. However, it should be noted that the anti-424 
ASGM-1 depletion strategy used in this study also has off-target effects on basophils 425 
98,100
. Simultaneous depletion of both NK and NKT cells inhibits the regenerative 426 
response after PHx, due to a reduction in the pro-regenerative cytokines TNF-α, IL-427 
6, HGF and IL-4 99. The authors suggest that cross talk occurs between NK/NKT 428 
cells and KCs and together this results in the production of pro-regenerative 429 
cytokines 99. Spatial correlation of KCs and NK cells in the sinusoids after PHx 430 
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supports this theory 97. Recent findings implicate ILCs and NK cells as the main 431 
producers of IL-22 post-PHx which is required for efficient liver regeneration 101.  432 
 433 
The contribution of NK/NKT cells to AILI is not fully elucidated. Early reports of a 434 
positive correlation between activation of NK/NKT cells and pathogenesis of AILI has 435 
been found linked to dimethyl sulfoxide (DMSO), a solvent used to dissolve APAP 436 
102,103
. DMSO can influence NK/NKT cell response and manipulating NK/NKT cells in 437 
the absence of DMSO failed to display any hepatoprotective effects 103.  438 
NK/NKT cells have been indirectly implicated in the pathogenesis of AILI. IFN-γ, 439 
mainly released by NK cells, has been implicated as a mediator of tissue injury and 440 
inflammation following AILI 68. Whereas, NKT cell deficient mice are more sensitive 441 
to APAP, as they show increased expression and activity of cytochrome P450 2E1 442 
(CYP2E1); an enzyme required for APAP metabolism 42. However, CYP2E1 443 
expression is only increased under starvation 42. So far there is no evidence to 444 
suggest either a direct protective or detrimental role of NK/NKT cells in the 445 
pathogenesis of AILI. ILCs have been shown to be have both protective and 446 
pathogenic roles in liver diseases such as viral hepatitis and fibrosis, however their 447 
specific role in AILI has not been investigated 104. As there are common cell surface 448 
markers between NK cells and ILCs. previous studies which define murine NK cells 449 
on the basis of NK1.1 and CD3 need to be re-evaluated 102,103.  450 
 451 
Adaptive lymphocytes 452 
 453 
T cells and B cells are major players in adaptive immunity, for example mediating 454 
cellular and humoral responses against pathogens and cancer cells 26. There are a 455 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
significant number of hepatic T cells, localized to the portal tracts and parenchyma in 456 
a healthy liver, which are phenotypically different from circulating lymphocytes 105. T 457 
cells are involved in maintaining tolerance in the liver, however they are also major 458 
players in hepatic injury and inflammation 106. The T cell compartment is comprised 459 
of highly heterogeneous cells and like macrophages, these cells are capable of 460 
mediating both pro-inflammatory or anti-inflammatory responses 70. CD4+ T cells (T 461 
helper or TH cells) and CD8+ T cells (cytotoxic T cells) are the two broad subtypes 462 
106
. Depending on transcriptional profiles and cytokine secretion, TH cells has been 463 
further divided into four main subsets (TH1, TH2, TH17 and regulatory TREG cells) 70. In 464 
addition to classical T cells, there are also a small proportion of non-classical T cells 465 
in the liver, termed γδ-T cells 70.  466 
 467 
The main evidence suggesting a role for adaptive lymphocytes in liver regeneration 468 
has come from experiments on RAG1-/- (T and B cell deficient) mice. Following PHx 469 
RAG1-/- mice show increased mortality and extensive hepatic injury, indicating that 470 
adaptive immune cells are critical in regulating liver regeneration 107. Using 471 
hepatocyte proliferation, measurement of necrosis and mortality as readouts, T cell 472 
specific knockout experiments demonstrate that both CD4+ and CD8+ T cells, but not 473 
γδ T cells are required for normal liver regeneration 107. This regulation occurs 474 
through a T cell-derived lymphotoxin (LT) axis, whereby LT expression by T cells 475 
promotes liver regeneration through direct hepatocyte contact and via the IL-6 476 
pathway 107. In addition to T cells,  B cells also express LT, but B cell derived LT has 477 
not been shown to be linked to liver regeneration 107.   478 
 479 
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The role of T cells in AILI has not been investigated in depth, but current research 480 
suggests that CD4+ T (TH) cells play a pivotal role while CD8+ T cells do not appear 481 
to modulate AILI 108. Experiments using different strains of mice have shown that the 482 
TH1/TH2 balance is importance in AILI; as TH1 dominant mice (C57BL/6) are more 483 
susceptible to AILI than TH2 dominant mice (BALB/c) 109. This difference was 484 
attributed to cytokine release, rather than differences in APAP metabolism. 485 
Expression of TNF-α and IFN-γ, was elevated in TH1 dominant mice 68,110 while TH2 486 
dominant mice had high expression of the hepatoprotective cytokine IL-6 107,109. 487 
There is also an increase in TREG cells in the liver post-AILI, and they display a 488 
protective phenotype, by suppressing inflammation and releasing hepatocyte 489 
mitogens such as IL-10 and TGF-β (Wang et al., 2015). Currently, we do not know 490 
the signals driving TREG accumulation in the liver following AILI. There is likely a 491 
complex interplay between TH1, TH2 and TREG subsets which may regulate both the 492 
progression and resolution of hepatic injury 108,109.  493 
 494 
Recently TH17 cells have been implicated in the immune response during the initial 495 
stages of AILI 111. TH17 cells increase significantly following APAP overdose and 496 
they have been identified as the main cell type to promote IL-17 signaling, which is 497 
associated with the release of pro-inflammatory and neutrophil-mobilizing cytokines 498 
111,112
. Furthermore, patients with AILI have increased levels of IL-17 and IL-21 499 
(another TH17-secreted cytokine) in their serum 113. IL-17 can be produced by many 500 
cell types, including NK cells and γδ T cells 113. During AILI, γδ T cells can have been 501 
shown to secrete IL-17, as a response to HMGB1-mediated release of IL-23 by 502 
hepatic macrophages 114. This interaction between macrophages and γδ T cells 503 
results in neutrophil recruitment into the injury sites, promoting inflammation 114 504 
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(Figure 2). Additionally, treatment with baicalin, a flavonoid compound has been 505 
found to elicit hepatoprotective effects in AILI, by attenuation of γδ T cells and IL-17 506 
expression 115.  507 
 508 
 509 
Conclusion 510 
 511 
It is clear that immune cells are key regulators of liver regeneration and repair. 512 
However, the precise role of specific immune cell subpopulations is highly context-513 
dependent, with both innate and adaptive immune cells playing very different roles at 514 
different stages of the disease process. Importantly, a broad categorization of cells 515 
as negative and positive regulators of liver regeneration is not sufficient, as many 516 
immune cells types are significantly more heterogeneous in terms of function than 517 
we previously appreciated. Further work to dissect the hepatic immune cell 518 
landscape at high resolution will greatly facilitate the identification and 519 
characterization of the key pro-regenerative immune cell subsets during liver injury 520 
and repair. Such studies will be essential to better define the immune components of 521 
the regenerative niche in the liver, which will guide the development of highly 522 
targeted therapeutic strategies to promote hepatic regeneration in patients with liver 523 
disease.  524 
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